David Tyronne Howton, Jr

2012

In 2012, David Tyronne Howton, Jr earned a total compensation of $2.8M as Senior Vice President, General Counsel and Corporate Secretary at Sarepta Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$29,006
Option Awards$2,760,570
Salary$59,856
Other$459
Total$2,849,891

Howton received $2.8M in option awards, accounting for 97% of the total pay in 2012.

Howton also received $29K in non-equity incentive plan, $59.9K in salary and $459 in other compensation.

Rankings

In 2012, David Tyronne Howton, Jr's compensation ranked 2,448th out of 11,487 executives tracked by ExecPay. In other words, Howton earned more than 78.7% of executives.

ClassificationRankingPercentile
All
2,448
out of 11,487
79th
Division
Manufacturing
848
out of 4,252
80th
Major group
Chemicals And Allied Products
188
out of 1,200
84th
Industry group
Drugs
109
out of 922
88th
Industry
Pharmaceutical Preparations
88
out of 697
87th
Source: SEC filing on April 30, 2015.

Howton's colleagues

We found seven more compensation records of executives who worked with David Tyronne Howton, Jr at Sarepta Therapeutics in 2012.

2012

Sandesh Mahatme

Sarepta Therapeutics

Chief Financial Officer

2012

David Howton

Sarepta Therapeutics

General Counsel

2012

Christopher Garabedian

Sarepta Therapeutics

Chief Executive Officer

2012

Edward Kaye

Sarepta Therapeutics

Chief Executive Officer

2012

Michael Jacobsen

Sarepta Therapeutics

Vice President, Finance

2012

Jayant Aphale

Sarepta Therapeutics

Senior Vice President, Technical Operations

2012

Effie Toshav

Sarepta Therapeutics

General Counsel

News

In-depth

You may also like